Drug utilization pattern, drug-related problems and associated risk factors in patients with hepatic impairment: a prospective observational study at a tertiary care teaching hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20263538Keywords:
Adverse drug reactions, Child-Pugh score, Drug-related problems, Drug utilization, Hepatic impairment, Rational prescribingAbstract
Background: Because the liver drives the clearance of most medicines, any decline in hepatic function reshapes drug handling and leaves patients open to drug-related problems (DRPs). We set out to map the drug utilization pattern, characterise the DRPs, and identify the risk factors linked to hepatic impairment in admitted patients.
Methods: A sample of 60 inpatients with hepatic impairment was studied prospectively over six months (February to August 2025) in the medicine ward of a tertiary care teaching hospital. Demographic, clinical, and prescription details were captured on structured forms. Severity was graded by the Child-Pugh score, prescribing quality was benchmarked against WHO core indicators, and DRPs were categorised by the Cipolle-Strand-Morley framework. Categorical associations were tested by chi-square, with the exact test for sparse cells; significance was set at p<0.05.
Results: Most patients were men (95.0%); the 41-60-year band was largest (45.0%) and moderate disease (Child-Pugh B) prevailed (76.7%). Altogether 714 drugs were prescribed (mean 11.9 per patient); antibiotics (19.2%) and proton-pump inhibitors (13.2%) led non-hepatospecific classes, and ursodeoxycholic acid (16.1%) the hepatospecific agents. Generic prescribing reached only 25.6%, while 74.9% featured on the WHO Essential Medicines List. Fifty DRPs occurred in 42 patients (70.0%), chiefly drug-drug interactions (40.0%) and adverse drug reactions (20.0%). Comorbidity was significantly associated with DRPs (exact test, p=0.024), and alcohol overconsumption was the leading risk factor (88.3%).
Conclusions: Prescribing leaned on antibiotics, acid suppressants, and hepatospecific agents, yet weak generic prescribing and a heavy comorbidity-driven DRP load mark clear openings for pharmacist-led optimisation and structured alcohol-abstinence counselling.
Metrics
References
Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017;377(8):756-68. DOI: https://doi.org/10.1056/NEJMra1610570
Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14):1486-500. DOI: https://doi.org/10.1056/NEJMra0801644
Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in North India. Emerg Med Int. 2014;2014:973578. DOI: https://doi.org/10.1155/2014/973578
World Health Organization. WHO model list of essential medicines, 23rd list, 2023. Available at: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02. Accessed 20 August 2025.
Babu S, Sadanandan S, Patel RP, Uttangi S. A study to assess prevalence and drug utilization pattern in hepatic impairment patients with or without comorbidities in a tertiary care teaching hospital. J Young Pharm. 2021;13(2):167-71. DOI: https://doi.org/10.5530/jyp.2021.13.34
Nayak G, Tom C, Skaria DM, Yasmeen N, Hameed F. A prospective observational study on drug utilization pattern and relation of alcohol consumption in patients with alcoholic liver disease in a tertiary care hospital. Indian J Pharm Pract. 2022;15(1):45-51. DOI: https://doi.org/10.5530/ijopp.15.1.4
Hadagali M, Upendra N, Venkatesh JS, Hazarika A. Prospective study of drugs used to treat hepatic impairment patients with or without comorbidities at a tertiary care teaching hospital. RGUHS J Pharm Sci. 2024;14(1):22-30. DOI: https://doi.org/10.26463/rjps.14_1_2
Kolasani BP, Sasidharan P, Divyashanthi CM, Jayabal P, Rajaseharan A. Prescribing pattern of drugs in patients with alcoholic liver disease in a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2017;7(5):538-44. DOI: https://doi.org/10.5455/njppp.2017.7.1233027012017
Twinkle MJ, Karjal RZ, Anushree A, Kellarai A, Shaji B, Shetty S, et al. Assessment of drug-related problems among patients of chronic liver disease in a tertiary care hospital. Ethiop J Health Sci. 2024;34(6):489-98. DOI: https://doi.org/10.4314/ejhs.v34i6.5
Kumar VS, Rahaman SK, Deepika T. Prevalence, general medication utilization, and cost-minimization analysis of drugs in hepatic impairment patients at a tertiary care hospital. Res J Pharm Technol. 2019;12(10):4873-8. DOI: https://doi.org/10.5958/0974-360X.2019.00844.8
Xue H, Wang L, Sun D, Wu Y, Yu C, Huang Y, et al. Associations of alcohol consumption and genetic predisposition to hepatic steatosis with liver-related events. Gastroenterology. 2025;169(2):312-24. DOI: https://doi.org/10.1053/j.gastro.2025.04.021
Eftekhari Z, Gholizadeh M. Drug utilization pattern of patients with alcoholic liver disease in a general hospital. Arch Pharm Pract. 2020;11(1):89-92.
Huma S, Fatima ON, Ayesha I. Prescribing pattern of drugs used in chronic liver disease with comorbid conditions and assessment of severity using MELD score: a prospective observational study. J Drug Deliv Ther. 2020;10(5-s):19-24. DOI: https://doi.org/10.22270/jddt.v10i5-s.4436
Zeebaish S, Hemalatha P, Eswari PV, Kodandaraman T, Lakshmi P, Apoorva G. A prospective observational study on prescribing patterns of drugs used in alcoholic liver disease patients at a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2017;6(6):1386-92. DOI: https://doi.org/10.18203/2319-2003.ijbcp20172228
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Prajwal S. Hallur, Aftabhusain Dhalayat, Vivek Kumar, Raghavendra S. Hegde
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
